U.S. Physical Therapy, Inc. (USPH)
| Market Cap | 1.49B +34.8% |
| Revenue (ttm) | 829.86M +10.5% |
| Net Income | -20.12M -32.5% |
| EPS | -1.33 |
| Shares Out | 14.93M |
| PE Ratio | n/a |
| Forward PE | 30.67 |
| Dividend | $1.84 (1.85%) |
| Ex-Dividend Date | Nov 16, 2026 |
| Volume | 148,432 |
| Open | 99.09 |
| Previous Close | 98.60 |
| Day's Range | 96.39 - 100.66 |
| 52-Week Range | 58.19 - 101.80 |
| Beta | 1.13 |
| Analysts | Buy |
| Price Target | 111.50 (+11.95%) |
| Earnings Date | Nov 4, 2026 |
About USPH
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance... [Read more]
Financial Performance
In 2025, U.S. Physical Therapy's revenue was $773.34 million, an increase of 16.39% compared to the previous year's $664.43 million. Earnings were $21.57 million, a decrease of -22.20%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for USPH stock is "Buy." The 12-month stock price target is $111.5, which is an increase of 11.95% from the latest price.
News
U.S. Physical Therapy price target raised to $122 from $110 at Barrington
Barrington raised the firm’s price target on U.S. Physical Therapy (USPH) to $122 from $110 and keeps an Outperform rating on the shares after hosting a meeting with management and…
U.S. Physical Therapy price target raised to $110 from $98 at Barrington
Barrington raised the firm’s price target on U.S. Physical Therapy (USPH) to $110 from $98 and keeps an Outperform rating on the shares. Adjusted EPS of 80c “easily beat our…
U.S. Physical Therapy management to meet with Barrington
Meeting to be held in Denver on November 10 hosted by Barrington.
U.S. Physical Therapy Earnings Call Transcript: Q3 2026
Q3 revenue grew 13% and EBITDA rose more than 16%, led by PT volume and hospital affiliations. FY EBITDA guidance was reaffirmed at $102 million-$106 million, while elevated employee health costs remained a margin headwind.
U.S. Physical Therapy Earnings release: Q3 2026
U.S. Physical Therapy released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
U.S. Physical Therapy Quarterly report: Q3 2026
U.S. Physical Therapy has published its Q3 2026 quarterly earnings report on November 5, 2026.
U.S. Physical Therapy reports Q3 adjusted EPS 80c, consensus 73c
Reports Q3 revenue $223M, consensus $214.54M. Chris Reading, Chairman and Chief Executive Officer commented, “We are pleased with the strong financial performance delivered in the third quarter 2026. ...
U.S. Physical Therapy backs FY26 adjusted EBITDA view $102M-$106M
16:29 EST U.S. Physical Therapy (USPH) backs FY26 adjusted EBITDA view $102M-$106M
USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call Dates
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy appoints Myra Davis to board of directors
U.S. Physical Therapy (USPH) announced that its Board of Directors approved the appointment of Myra Davis to serve as a member of the Board, effective October 1. Davis currently serves…
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy price target raised to $95 from $90 at JPMorgan
JPMorgan raised the firm’s price target on U.S. Physical Therapy (USPH) to $95 from $90 and keeps an Overweight rating on the shares. The firm updated the company’s model. Published…
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy Transcript: 17th Annual Midwest IDEAS Conference
A unique partnership-driven model and disciplined acquisition strategy have enabled steady growth, with a new 10-year NYU Langone alliance expected to boost patient volumes and margins. The injury prevention division continues to expand, and recent reimbursement trends are turning favorable.
U.S. Physical Therapy appoints Etta as Chief Financial Officer
U.S. Physical Therapy (USPH) announced that Nchacha Etta will serve as the Company’s Executive Vice President and Chief Financial Officer, effective as of September 1, 2026. Jason Curtis, the Company’...
U.S. Physical Therapy Announces CFO
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy price target raised to $98 from $90 at Barrington
Barrington raised the firm’s price target on U.S. Physical Therapy (USPH) to $98 from $90 and keeps an Outperform rating on the shares, citing increasing confidence regarding FY27 and beyond…
U.S. Physical Therapy Earnings Call Transcript: Q2 2026
Q2 2026 delivered record clinic volumes and strong revenue growth, driven by hospital affiliations and rate increases across payer types. Margins were pressured by higher healthcare costs and pre-hiring, but guidance for 2026 was reaffirmed, with significant margin lift expected as integration completes.
U.S. Physical Therapy Earnings release: Q2 2026
U.S. Physical Therapy released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
U.S. Physical Therapy Quarterly report: Q2 2026
U.S. Physical Therapy has published its Q2 2026 quarterly earnings report on August 6, 2026.
U.S. Physical Therapy Slides: Q2 2026
U.S. Physical Therapy has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
U.S. Physical Therapy reports Q2 adjusted EPS 75c, consensus 84c
Reports Q2 revenue $214.1M, consensus $211.36M. Chris Reading, Chairman and Chief Executive Officer commented, “Our second quarter 2026 results include an important milestone for USPH as we completed ...
U.S. Physical Therapy backs FY26 adjusted EBITDA view $102M-$106M
16:26 EDT U.S. Physical Therapy (USPH) backs FY26 adjusted EBITDA view $102M-$106M
USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...